Company Introduction
Dorrapharma is engaged in R&D, manufacture and market of intermediates, API and formulation. The services supplied are included in material sourcing, route selection, process & analytical development, custom synthesis and etc.
The API sites are approved by CFDA, PMDA, EU authorities and the total reactor capacity is 2,000,000L and the output is about 5,000 tons per year. The therapeutic areas cover anti-infection, anti-virus, digestive system, cardiovascular system and etc.
Main Competitive Advantages
Experienced R&D Staff,Production Capacity,Contract Manufacturing (CRO,CMO),Quality Service,